Shared Decision Making in Hemophilia Patient Care is a grant from Pfizer Foundation Inc. that funds independent quality improvement and medical education initiatives focused on advancing shared decision-making models in hemophilia patient care in China. Supported projects may include research, education programs, or quality improvement efforts designed to improve outcomes for patients with hemophilia in areas of unmet medical need.

Eligible applicants are healthcare organizations and professional institutions based in China. This grant aligns with Pfizer's global health commitment to supporting patient-centered care in underserved communities worldwide.

Clinical Trials in Children Integrity and Transparency Plain Language Study Results Expanded Access & Compassionate Use Inflammation & Immunology PfizerPro for Professionals Patient Assistance Programs Behind the Science Features Patient Advocacy & Engagement Diversity, Equity, and Inclusion Environmental Sustainability Stem Cell Research Policy Working with Healthcare Professionals Prescription Value & Pricing Corporate Governance Overview Board Committees & Charters The Pfizer Board Policies Corporate Governance FAQs Research and Business Development Partnerships Submit Your Opportunities Suggestions within Pfizer.

com Funding Global Health Through Grants Our grant programs support independent research, quality improvement and education initiatives that find innovative ways to improve patient outcomes in underserved communities around the world.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s areas of interest.

Independent Medical Education Investigator Sponsored Research Behind the Science: A New Path to Tackling Metastatic Breast Cancer In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.

Hiding in Plain Sight: The Racial Toll of Lyme Disease Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease. Behind the Science: Breaking the Cycle of C.

difficile The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.

Achieving breakthroughs that change patients’ lives across the globe, especially in underserved communities or disaster-affected communities, is our goal. Which is why we take the health and safety of our colleagues so seriously. We want to share the power of our resources to achieve a healthier world for everyone.

We’re committed to using everything at our disposal—from our medicines and vaccines, to our financial investments and colleagues’ expertise—all in the name of providing quality healthcare services for patients everywhere.

And because our resources allow us to reach so many people, we’re committed to using our global presence and scale to make a difference throughout the world Working with Healthcare Professionals Prescription Pricing and Value Incredible things can happen when people come together with one shared goal.

The future of medicine is happening here, and we’re eager to work alongside inspired and inspirational people who want to improve health around the world. Opportunities for Veterans Leadership. Honor.

A sense of purpose. The qualities you demonstrated as a member of the armed forces are valued at Pfizer. Explore Veteran Opportunities We’re turning advanced science and technologies into therapies that make a real difference.

Join us, and your efforts could impact millions of people. Breakthrough Fellowship Program We want to create a workplace for all. That’s why we’re committed to increasing diversity and fostering inclusivity with this first-of-its-kind, nine-year fellowship program.

Explore Our Fellowship Program Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere. This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.